examined whether cholesterol-coated PLGA-NPs carrying retinoic acid, in combination with an anti-PD-L1 checkpoint inhibitor, could mitigate interactions between TAMs and CRC cells. The gene discussed is CD274; the disease is colorectal carcinoma.